-

Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry Training Course: Regulatory Affairs, Sales, Quality, and Analytical Departments (ONLINE EVENT: Apr 20th - Apr 21st, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "The Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry Training Course (Apr 20th - Apr 21st, 2026)" training has been added to ResearchAndMarkets.com's offering.

This course will benefit nitrosamine decision makers and those who can benefit from a broader understanding of the full picture of nitrosamines in regulatory affairs, sales, quality, and analytical departments.

Nitrosamine regulations are the most impactful change to our industry in recent years, affecting 30% of current and new products, including generics. Regulatory expectations have changed frequently and vary globally. In this webinar, we will discuss the major requirements and strategies. Those new to the subject and those growing their nitrosamine team will find value in seeing the entire picture. Experienced Small and Medium-sized Enterprises (SMEs) will receive detailed instructions for common pain points, like risk assessments.

Benefits of attending

  • Enhance your understanding of current regulatory framework and recent changes
  • See the full scope of work for your team members to understand how their part fits with the whole
  • Learn best practices for risk assessments
  • Inform next steps when your product is near or above regulatory limits through remediation, control strategies, and new research
  • Example products guide the way to practical understanding

Certification:

  • CPD: 6 hours for your records
  • Certificate of completion

Key Topics Covered:

Day 1

  • History and background
  • Classes of nitrosamines
  • Regulatory update
  • Team building
  • Risk assessments
  • At risk structures
  • Limit determination

Day 2

  • Nitrosation Assay Procedure (NAP) test
  • Analytical instruments and methods
  • Control strategy
  • Remediation
  • Post approval changes
  • Where are we going? Future state and unanswered questions

Speakers:

Jason Brown

Adare Pharma Solutions

Jason Brown brings a wealth of knowledge and practical experience to his role as Senior Analytical Sciences Manager at Adare Pharma Solutions, where he serves as the global nitrosamine subject matter expert. He has led Adare's innovative approaches to understanding nitrosamine formation, measurement, and mitigation to ensure regulatory compliance internally and for our customers. Jason has led numerous dialogues on the subject of nitrosamines through panel discussions, webinars, posters, articles, and regular contributions to the USP Nitrosamine Forum. Jason has a BS in Chemistry from George Fox University.

For more information about this training visit https://www.researchandmarkets.com/r/vv2bgh

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom